Table 6.
Multivariate analysis adjusted FcγRIIIa-F158V
Multivariate, not adjusted for FcγRIIIa-F158V | PBonf | Multivariate analysis with adjustment for FcγRIIIa-F158V genotype and allele carriage | ||||||
---|---|---|---|---|---|---|---|---|
F158V genotype | PBonf | ≥1 158F allele | PBonf | ≥1 158V allele | PBonf | |||
Maternal | ||||||||
FcγRIIa (rs1801274) | ||||||||
131RR genotype | ||||||||
Total transmitting | P = 0.023 | ns | 1.93 (0.82–4.57), P = 0.133 | ns | 2.25 (0.97–5.24), P = 0.133 | ns | 2.08 (0.89–4.86), P = 0.091 | ns |
In utero transmitting | P = 0.029 | ns | 9.37 (1.01–87.22), P = 0.049 | ns | 9.59 (1.05–87.37), P = 0.045 | ns | 10.26 (1.12–94.28), P = 0.040 | ns |
In utero-enriched transmitting | P = 0.048 | ns | 1.94 (0.66–5.70), P = 0.226 | ns | 2.60 (0.90–7.52), P = 0.077 | ns | 1.98 (0.67–5.80), P = 0.214 | ns |
≥1 131H allele | ||||||||
In utero transmitting | P = 0.045 | ns | 0.42 (0.14–1.29), P = 0.132 | ns | 0.40 (0.14–1.15), P = 0.088 | ns | 0.39 (0.13–1.18), P = 0.096 | ns |
≥1 131R allele | ||||||||
Total transmitting | P = 0.049 | ns | 1.80 (0.84–3.85), P = 0.128 | ns | 1.90 (0.89–4.05), P = 0.095 | ns | 1.91 (0.90–4.06), P = 0.091 | ns |
FcγRIIb (rs1050501) | ||||||||
232TT genotype | ||||||||
Total transmitting | P = 0.030 | ns | 2.06 (0.78–5.41), P = 0.144 | ns | 2.48 (0.96–9.36), P = 0.060 | ns | 2.17 (0.83–5.67), P = 0.115 | ns |
≥1 232I allele | ||||||||
Total transmitting | P = 0.043 | ns | 0.49 (0.20–1.20), P = 0.118 | ns | 0.43 (0.18–1.05), P = 0.063 | ns | 0.48 (0.20–1.18), P = 0.110 | ns |
FcγRIIIb | ||||||||
≥1 HNA1b allotype | ||||||||
Total transmitting | P = 0.014 | ns | 2.26 (1.22–4.17), P = 0.009 | ns | 2.19 (1.20–4.02), P = 0.011 | ns | 2.21 (1.20–4.11), P = 0.011 | ns |
In utero-enriched transmitting | P = 0.031 | ns | 2.43 (1.15–5.16), P = 0.020 | ns | 2.32 (1.11–4.82), P = 0.025 | ns | 2.40 (1.13–5.10), P = 0.023 | ns |
Infant | ||||||||
FcγRIIIb | ||||||||
HNA1a+/1b−/1c− genotype | ||||||||
Total infected | P = 0.033 | ns | 0.37 (0.15–0.93), P = 0.034 | ns | 0.37 (0.15–0.91), P = 0.031 | ns | 0.37 (0.15–0.93), P = 0.034 | ns |
Intrapartum infected | P = 0.044 | ns | 0.20 (0.04–0.96), P = 0.044 | ns | 0.19 (0.04–0.95), P = 0.043 | ns | 0.20 (0.04–0.96), P = 0.044 | ns |
HNA1a+/1b+/1c+ genotype | ||||||||
In utero-enriched infected | P = 0.032 | ns | 5.67 (1.39–23.11), P = 0.016 | ns | 4.47 (1.13–17.64), P = 0.032 | ns | 5.74 (1.39–23.57), P = 0.015 | ns |
≥1 HNA1b allotype | ||||||||
Total infected | P = 0.019 | ns | 2.11 (1.16–3.83), P = 0.014 | ns | 2.04 (1.12–3.69), P = 0.019 | ns | 2.08 (1.15–3.77), P = 0.016 | ns |
In utero-enriched infected | P = 0.037 | ns | 2.29 (1.10–4.76), P = 0.026 | ns | 2.22 (1.07–4.58), P = 0.032 | ns | 2.26 (1.09–4.68), P = 0.028 | ns |
P values less than 0.05 are indicated in italics
P Bonf Bonferroni corrected P value, AOR adjusted odds ratio, CI confidence interval, VL viral load, bwt birth weight, ns not statistically significant
–, the variable of interest was not detected in any of the cases and thus could not be analysed